Skip to main content
SpringerLink
Log in

Applications of telomerase in urologic oncology

  • Published:
World Journal of Urology Aims and scope Submit manuscript

Summary

Vertebrates have special structures at the ends of their chromosomes, known as telomeres, which are composed of 5- to 15-kb pairs of a guanine-rich hexameric repeat (TTAGGG)n. In normal somatic cells there is a progressive degradation of telomeres with aging., The cell can afford to lose only a finite number of these telomeres before significant sequences of the parent DNA are lost, resulting in chromosomal instability and cell death. However, germ-cell telomeres are maintained despite multiple rounds of replication. This suggests that they produce an enzyme that maintains their telomere length. This enzyme, a ribonucleoprotein, is called telomerase. In this review, we discuss the presence of telomerase activity in various human cancers and, in particular, in urologic tumors. We describe the potential clinical utility of detection of the presence of telomerase activity in cells from voided urine samples of patients with bladder cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Adamson DJA, King DJ, Haites NE (1992) Significant telomere shortening in childhood leukemia. Cancer Genet Cytogenet 61: 204–205

    Google Scholar 

  2. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW, Harley CB (1992) Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 89: 10114–10118

    Google Scholar 

  3. Badalament RA. Fair WF, Whitmore WF Jr, Melamed MR (1988) The relative value of cytometry and cytology in the management of bladder cancer: the Memorial Sloan-Kettering Cancer Center experience. Semin Urol 6: 22

    Google Scholar 

  4. Blackburn EH (1991) Structure and function of telomeres. Nature 350: 569–573

    Google Scholar 

  5. Blackburn EH (1992) Telomerases. Annu Rev Biochem 61: 113–129

    Google Scholar 

  6. Blackburn EH (1994) Telomeres: no end in sight. Cell 77: 621–623

    Google Scholar 

  7. Blasco MA, Rizen M, Greider CW, Hanahan D (1996) Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nature Genet 12: 200–204

    Google Scholar 

  8. Bryan TM, Englezou A, Gupta J Bacchetti S, Reddel RR (1995) Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 14: 4240–4248

    Google Scholar 

  9. Carpinito GA, Stadler WM, Briggman JV, Chodak GW, Church PA, Lamm DL, Lange PH, Messing EM, Pasciak RM, Reservitz GB, Ross RN, Rukstalis DB, Sarosky MF, Soloway MS, Thiel RP, Vogelzang N, Hayden CL (1996) Urinary nuclear matrix protein as marker for transitional cell carcinoma of urinary tract. J Urol 156: 1280

    Google Scholar 

  10. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S (1992) Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 11: 1921–1929

    Google Scholar 

  11. Counter CM, Hirte HW, Bacchetti S, Harley SB (1994) Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 91: 2900–2904

    Google Scholar 

  12. De Lange T, Shiue L, Myers RM, Cox DR, Naylor SL, Killery AM, Varmus HE (1990) Structure and variability of human chromosome ends. Mol Cell Biol 10: 518–527

    Google Scholar 

  13. D'Hatlewin M-A, Baert L (1996) Initial evaluation of the bladder tumor antigen test in superficial bladder cancer. J Urol 155: 475

    Google Scholar 

  14. Fett-Conte AC, Liedtke H Jr, Chaves H, Thome JA, Tajara EH (1993) Telomeric fusions in a Wilms' tumor. Cancer Genet Cytogenet 69: 141–145

    Google Scholar 

  15. Gamarra MC, Zein T (1984) Cytologic spectrum of bladder cancer. Urology 23 [Suppl 3]: 23

    Google Scholar 

  16. Greaves M (1996) Telomerase activation, stem cells and cancer. Trends Genet 12: 127–128

    Google Scholar 

  17. Harley CB, Futcher AB, Greider CW (1990) Telomeres shorten during aging. Nature 345: 458–460

    Google Scholar 

  18. Hastie HD, Dempster M, Dunlop MG, Thompson AM, Green DK, Attshire RC (1990) Telomere reduction in human colorectal carcinoma and with aging. Nature 346: 866–868

    Google Scholar 

  19. Hiyama E, Yokoyama T, Hiyama K, Yamakido M, Santo T, Kodama T, Ichikawa T, Matsuura Y (1994) Alteration of telomeric repeat length in adult and childhood adult solid neoplasias. Int J Oncol 6: 13–16

    Google Scholar 

  20. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW (1995) Correlating telomerase activity levels with human neuroblastma outcomes. Nature Med 1: 249–255

    Google Scholar 

  21. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y, Kodama T, Piatyszek M, Shay JW, Matsuura Y (1995) Telomerase activity in gastric cancer. Cancer Res 55: 3258–3262

    Google Scholar 

  22. Hiyama E, Gollahon L; Kataoka T, Juroi K, Yokoyama T, Gazdar AF, Hiyama K, Piatyszek MA, Shay JW (1996) Telomerase activity in human breast tumors. J Natl Cancer Inst 88: 116–122

    Google Scholar 

  23. Holt SE, Shay JW, Wright WE (1996) Refining the telomeretelomerase hypothesis of aging and cancer. Nature Biotechnol 14: 836–839

    Google Scholar 

  24. Holt SE, Wright WE, Shay JW (1996) Regulation of telomerase activity in immortal cell lines. Mol Cell Biol 16: 2932–2939

    Google Scholar 

  25. Kavaler E, Shu WP, Change Y, Droller MJ, Liu BCS (1997) Detection of human bladder cancer cells in voided urine samples by assaying for the presence of telomerase activity. J Urol (in press)

  26. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL, Shay JW (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011–2015

    Google Scholar 

  27. Mehle C, Ljung berg B, Roos G (1994) Telomere shortening in renal cell carcinoma. Cancer Res 54: 236–241

    Google Scholar 

  28. Nichols G, Khaled Z, Telang NT, Narayanan R (1995) Differentiation of immortal cells inhibits telomerase activity. Proc Natl Acad Sci USA 92: 12343–12346

    Google Scholar 

  29. Ohmura H, Tahara H, Suzuki M, Ide T, Shimizu M, Yoshida MA, Tahara E, Shay JW, Barrett JC, Oshimura M (1995) Restoration of the cellular sensescence program and repression of telomerase by human chromosome 3. Jpn J Cancer Res 86: 899–904

    Google Scholar 

  30. Olovinkov AM (1973) A theory of marginotomy. J Theor Biol 41: 181–190

    Google Scholar 

  31. Pathak S, Wang Z, Dhaliwak MK, Sacks PC (1988) Telomeric association: another characteristic of cancer chromosomes? Cytogenet Cell Genet 47: 227–229

    Google Scholar 

  32. Rabb SS, Lenel J, Cohen MB (1994) Low grade transitional cell carcinoma of the bladder. Cytologic diagnosis by key features as identified by logistic regression analysis. Cancer 74: 1621

    Google Scholar 

  33. Saltman D, Ross FM, Fantes JA, Allshire RC, Turner GE, Evans HG (1989) Telomeric associations in a lymphoblastoid cell line from a patient with B-cell follicular lymphoma. Cytogenet Cell Genet 50: 230–233

    Google Scholar 

  34. Sawyer JR, Goosen LS, Stine KC, Thomas JR (1994) Telomeric fusion as a mechanism for the progressive loss of the short arm of chromosome 11 in an anaplastic Wilm's tumor. Cancer 74: 767–773

    Google Scholar 

  35. Shay JW, Wright WE (1996) The reactivation of telomerase activity in cancer progression. Trends Genet 12: 129–131

    Google Scholar 

  36. Skowronski RJ, Peenl DM, Feldman D (1993) Vitamin D and prostate cancer: 1,25-dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines. Endocrinology 132: 1952–1960

    Google Scholar 

  37. Soloway MS, Briggman JV, Carpinito GA, et al. (1996) Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. J Urol 156: 363

    Google Scholar 

  38. Sommerfeid H-J, Meeker AK, Piatyszek MA, Bova GS, Shay JW, Coffey DS (1996) Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res 56: 218–222

    Google Scholar 

  39. Wright WE, Shay JW (1996) Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents. Clin Cancer Res 2: 799–803

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Mount Sinai School of Medicine, One Gustave Levy Place, Box 1272, 10029, New York, NY, USA

    Jaime Landman, Elizabeth Kavaler, Michael J. Droller & Brian C. -S. Liu

Authors
  1. Jaime Landman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elizabeth Kavaler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael J. Droller
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Brian C. -S. Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Landman, J., Kavaler, E., Droller, M.J. et al. Applications of telomerase in urologic oncology. World J Urol 15, 120–124 (1997). https://doi.org/10.1007/BF02201983

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02201983

Keywords

Search

Navigation